Clover Health Investments, Corp. (CLOV)
CLOV Stock Price Chart
Explore Clover Health Investments, Corp. interactive price chart. Choose custom timeframes to analyze CLOV price movements and trends.
CLOV Company Profile
Discover essential business fundamentals and corporate details for Clover Health Investments, Corp. (CLOV) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Healthcare Plans
IPO Date
12 Jun 2020
Employees
570.00
Website
https://www.cloverhealth.comCEO
Andrew Toy
Description
Clover Health Investments, Corp. is a U.S.-based firm specializing in Medicare Advantage insurance. The company leverages its proprietary software platform, the Clover Assistant, to provide both Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) health plans for individuals eligible for Medicare. In addition to its insurance operations, Clover Health also engages in non-insurance-related business ventures. The company was established in 2014 and its main office is located in Franklin, Tennessee.
CLOV Financial Timeline
Browse a chronological timeline of Clover Health Investments, Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Aug 2026
EPS estimate is $0.05, while revenue estimate is $728.27m.
Earnings released on 6 May 2026
EPS came in at $0.07 matching the estimated $0.07, while revenue for the quarter reached $749.19m , beating expectations by +4.80%.
Earnings released on 26 Feb 2026
EPS came in at -$0.05 surpassing the estimated -$0.10 by +51.04%, while revenue for the quarter reached $487.71m , beating expectations by +4.42%.
Earnings released on 4 Nov 2025
EPS came in at -$0.05 falling short of the estimated $0.02 by -350.00%, while revenue for the quarter reached $496.65m , beating expectations by +6.34%.
Earnings released on 5 Aug 2025
EPS came in at $0.03 matching the estimated $0.03, while revenue for the quarter reached $477.62m , beating expectations by +1.99%.
Earnings released on 6 May 2025
EPS came in at $0.05 surpassing the estimated -$0.07 by +171.43%, while revenue for the quarter reached $462.33m , missing expectations by -0.99%.
Earnings released on 27 Feb 2025
EPS came in at -$0.04 surpassing the estimated -$0.07 by +42.86%, while revenue for the quarter reached $336.96m , missing expectations by -3.01%.
Earnings released on 6 Nov 2024
EPS came in at -$0.02 falling short of the estimated -$0.01 by -50.04%, while revenue for the quarter reached $330.99m , missing expectations by -4.90%.
Earnings released on 5 Aug 2024
EPS came in at $0.01 surpassing the estimated -$0.05 by +120.00%, while revenue for the quarter reached $356.26m , beating expectations by +5.17%.
Earnings released on 7 May 2024
EPS came in at -$0.05 surpassing the estimated -$0.07 by +28.57%, while revenue for the quarter reached $346.92m , beating expectations by +8.00%.
Earnings released on 12 Mar 2024
EPS came in at -$0.12 surpassing the estimated -$0.18 by +33.33%, while revenue for the quarter reached $510.25m , beating expectations by +6.25%.
Earnings released on 6 Nov 2023
EPS came in at -$0.09 surpassing the estimated -$0.10 by +10.00%, while revenue for the quarter reached $306.03m , missing expectations by -36.08%.
Earnings released on 8 Aug 2023
EPS came in at -$0.06 surpassing the estimated -$0.13 by +53.85%, while revenue for the quarter reached $320.14m , missing expectations by -34.77%.
Earnings released on 9 May 2023
EPS came in at -$0.15 surpassing the estimated -$0.19 by +21.05%, while revenue for the quarter reached $321.99m , missing expectations by -35.44%.
Earnings released on 28 Feb 2023
EPS came in at -$0.23 surpassing the estimated -$0.34 by +32.35%, while revenue for the quarter reached $898.79m , beating expectations by +14.43%.
Earnings released on 7 Nov 2022
EPS came in at -$0.16 surpassing the estimated -$0.31 by +48.39%, while revenue for the quarter reached $856.82m , beating expectations by +7.17%.
Earnings released on 8 Aug 2022
EPS came in at -$0.22 surpassing the estimated -$0.23 by +4.35%, while revenue for the quarter reached $846.70m , beating expectations by +3.94%.
Earnings released on 9 May 2022
EPS came in at -$0.19 surpassing the estimated -$0.24 by +20.83%, while revenue for the quarter reached $874.38m , beating expectations by +11.04%.
Earnings released on 28 Feb 2022
EPS came in at -$0.44 falling short of the estimated -$0.26 by -69.23%, while revenue for the quarter reached $432.04m , beating expectations by +5.86%.
Earnings released on 9 Nov 2021
EPS came in at -$0.08 surpassing the estimated -$0.31 by +74.19%, while revenue for the quarter reached $427.16m , beating expectations by +2.24%.
Dividend declared on 23 Aug 2021
A dividend of $0.10 per share was announced, adjusted to $0.10.
Earnings released on 11 Aug 2021
EPS came in at -$0.45 falling short of the estimated -$0.17 by -164.71%, while revenue for the quarter reached $412.47m , meeting expectations.
CLOV Stock Performance
Access detailed CLOV performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
